Sore Throat News and Research

RSS

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Gen-Probe Incorporated announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.

25 Nov 2009

HealthPartners' health plans ranked top in Minnesota

HealthPartners is among the top 25 best private health plans in the nation and the top ranked plan in Minnesota according to U.S. News & World Report/NCQA “America's Best Health Insurance Plans 2009-10.” The report measures how well health plans perform on 50 measures of health care and member satisfaction. Two hundred thirty nine health plans from across the nation are included in the report. The top 50 health plans, including HealthPartners, are listed in the Nov. 16, 2009 print edition of U.S. News & World Report.

16 Nov 2009

New incisionless GERD treatment under trial

Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.

11 Nov 2009

New visitation guidelines to prevent novel flu spread

The New Jersey Hospital Association has issued new visitation guidelines for the state's hospitals to help them protect patients, staff and visitors from H1N1 influenza.

11 Nov 2009

Gastroschisis may be associated with infections during pregnancy

Results of an investigation conducted by University of Nevada, Reno researchers, public health officials and area physicians published this week in the Archives of Pediatrics & Adolescent Medicine, indicate that Washoe County experienced a cluster of a particular birth defect, gastroschisis, during the period April 2007 - April 2008.

7 Nov 2009

Five-year old Pennsylvanian boy dies of H1N1 flu complications

The Department of Health today confirmed that a five-year old Adams County boy died on Oct. 31 as a result of complications from H1N1 flu. This is Pennsylvania's first pediatric death associated with H1N1.

4 Nov 2009

superDimension's electromagnetic navigational bronchoscopy device receives AMA Category I CPT code

superDimension, Inc.®, a private company that develops minimally invasive interventional pulmonology devices, announced today that The American Medical Association (AMA) has issued a new Category I CPT® code for the use of the Company's electromagnetic navigational bronchoscopy (ENB) device to navigate to lesions or spots deep in the lungs.

4 Nov 2009

Four abstracts on RSV and influenza prevention in pediatric health to be presented

MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health.

31 Oct 2009

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

Recent news articles regarding Swine Flu H1N1 have been widespread. The virulence of the strain among humans and its implications for pandemic disease in humans may lead to increased interest in homeopathic treatments for Swine Flu H1N1.

29 Oct 2009

eHealthInsurance releases answers for FAQs on swine flu and their health insurance

eHealthInsurance (NASDAQ: EHTH) today released a list of answers to questions frequently asked from people concerned about the H1N1 virus (also called swine flu) and their health insurance, who have called into its Customer Care Center, which includes a call center staffed with licensed insurance agents. Getting answers to these questions is particularly important for high-risk individuals: pregnant women, children and seniors.

22 Oct 2009

Swine flu outbreak at USAFA: Investigators study behavior of the nH1N1 virus

With the 2009 influenza season upon us, characterization of the epidemiology and duration of shedding for the nH1N1 virus is critical. Investigators from the U.S. Air Force Academy and the U.S. Air Force School of Aerospace Medicine Epidemiology Consult Service capitalized on a unique opportunity to gain valuable insights about the natural behavior of the nH1N1 virus, including shedding patterns, during a recent large-scale swine flu outbreak at the U.S. Air Force Academy (USAFA).

20 Oct 2009

California's community hospitals launch public education and media campaign on H1N1

As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.

19 Oct 2009

CVS Caremark's seasonal flu shot clinics to run through October 22

CVS/pharmacy announced today that its seasonal flu shot clinics will run through October 22, in light of manufacturer delays in delivery of seasonal flu vaccine affecting all health care providers. However, MinuteClinic will continue to administer seasonal flu vaccines at its 500 locations in 25 states throughout the flu season with the supply of vaccine replenished as frequently as possible.

19 Oct 2009

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met® (pioglitazone HCl and metformin HCl) as initial therapy reached the study goal of hemoglobin A1c (HbA1c) of less than or equal to 7 percent compared to either component alone.

15 Oct 2009

Presentations on seasonal influenza and H1N1 viruses

Weill Cornell Medical College in Qatar hosted a detailed talk about a virus that's causing concern around the world. The recent cause of an interruption in local school openings, H1N1 information was presented in timely fashion by Dr. Abdullatif Al-Khal, head of the communicable disease unit at Hamad Medical Corporation, and Dr. Ravinder Mamtani, Professor of Public Health at WCMC-Q.

30 Sep 2009

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.

28 Sep 2009

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

Merck & Co., Inc., which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) for JANUVIA® tablets and JANUMET® tablets recommending their use as add-on to insulin for the treatment of type 2 diabetes.

26 Sep 2009

Children’s Hospital offers tips on H1N1 and seasonal flu

With the early onset of flu season coinciding with the start of school this year, parents are concerned about the flu. Experts from The Children’s Hospital in Denver, Colo., offer a pediatric perspective on all types of flu, including H1N1, also known as swine flu.

23 Sep 2009

U.S. HHS orders for an additional 29 million doses of MedImmune's influenza vaccine

MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza vaccine (LAIV) against the 2009 H1N1 influenza virus. This brings HHS orders to date to more than 40 million vaccine doses, with a total cumulative contract value of approximately $453 million.

22 Sep 2009

Tips for preventing mold exposure

In recognition of Mold Awareness Month this month, cleanup and restoration professionals are explaining how mold can affect anyone who is exposed to it.

19 Sep 2009